Clinical trial for Opioid Use Disorder
Official title Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
ClinicalTrials.gov ID: NCT06513156
What this study is testing
- What it's testing
- The study compares a new integrated clinic to usual care to see if it lowers infection‑related readmissions and improves health outcomes.
- Who it's for
- Adults hospitalized for an infection caused by injecting opioids or stimulants.
- What's involved
- Participants will be assigned to either the integrated clinic or standard care, and will attend scheduled visits and receive treatment as directed.
- Time commitment
- The trial lasts until the participant’s follow‑up period ends, with visits scheduled as needed by the assigned care plan.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Admitted to study hospital (defined as hospitalized with a primary team that is not Emergency Medicine)
- Injection opioid or stimulant use in past 90 days - per patient self-report
- Non-vertebral osteomyelitis
- Vertebral osteomyelitis or discitis
You likely can't join if
- 1\. Infection due to a cause other than injection drug use, per determination of a site PI.
- 2\. Inability to provide consent due to circumstance (e.g., sedated, intubated), language, or cognitive impairment.
- 3\. Unwilling to provide informed consent 4. Unable to receive potential interventions due to geography 5.
See the full eligibility criteria
- Age ≥ 18 years
- Admitted to study hospital (defined as hospitalized with a primary team that is not Emergency Medicine)
- Injection opioid or stimulant use in past 90 days - per patient self-report
- Non-vertebral osteomyelitis
- Vertebral osteomyelitis or discitis
- Epidural, subdural, or extradural abscess
- Intracranial or intraspinal abscess
- Native joint septic arthritis
- Prosthetic joint septic arthritis
- Blood stream infection (bacterial or fungal)
- Native valve Endocarditis
- Prosthetic valve endocarditis
- Cardiac Implantable electronic device infection
- Infectious pseudoaneurysm and aneurysm
- Infected vascular graft
- Septic venous thrombosis
- Skin and Soft tissue infection (cellulitis, skin abscess, necrotizing fasciitis)
- Infected skin ulcer
- Orthopedic hardware infection
- Muscle abscess/myositis
- Central nervous system infection (bacterial or fungal)
- Bacterial or fungal ophthalmologic infection
- Other abscess
- Pulmonary septic emboli
- Other acute bacterial or fungal infection deemed appropriate by site study team
- 1\. Infection due to a cause other than injection drug use, per determination of a site PI.
- 2\. Inability to provide consent due to circumstance (e.g., sedated, intubated), language, or cognitive impairment.
- 3\. Unwilling to provide informed consent 4. Unable to receive potential interventions due to geography 5. On comfort measures or planned for discharge to hospice care 6. Incarcerated at the time of hospitalization 7.
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
- Atlanta, Georgia, United States
- Baltimore, Maryland, United States
- Morgantown, West Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States; Atlanta, Georgia, United States; Baltimore, Maryland, United States; Morgantown, West Virginia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.